Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study

Over the past 20 years, Pulmonary Arterial Hypertension (PAH) patients and providers have seen an increase in options to treat PAH. Currently, there are choices for the delivery of medications approved to treat patients with PAH where at one point the only option was intravenous (IV) therapy. This c...

Full description

Bibliographic Details
Main Authors: Tina Hyman, Michael Salinero, Francisco Javier Jimenez-Carcamo, Margarita Pallares, Maribel Matos
Format: Article
Language:English
Published: Library & Knowledge Services and Nursing & Health Sciences Research Departments 2019-07-01
Series:Nursing & Health Sciences Research Journal
Subjects:
Online Access:https://scholarlycommons.baptisthealth.net/nhsrj/vol2/iss1/8/
id doaj-23d41a48e1b14b06abfd7e27c226cf23
record_format Article
spelling doaj-23d41a48e1b14b06abfd7e27c226cf232020-11-24T21:44:36ZengLibrary & Knowledge Services and Nursing & Health Sciences Research DepartmentsNursing & Health Sciences Research Journal2578-37502019-07-01213640Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case StudyTina Hyman0Michael Salinero1Francisco Javier Jimenez-Carcamo2Margarita Pallares3Maribel Matos4South Miami HospitalSouth Miami HospitalBaptist Health South FloridaSouth Miami HospitalSouth Miami HospitalOver the past 20 years, Pulmonary Arterial Hypertension (PAH) patients and providers have seen an increase in options to treat PAH. Currently, there are choices for the delivery of medications approved to treat patients with PAH where at one point the only option was intravenous (IV) therapy. This case study details the transition from IV Epoprostenol to oral Treprostinil for the treatment of a 53 year old female diagnosed with severe Pulmonary Arterial Hypertension whose quality of life became unbearable by the IV medication delivery route. This patient was a synchronized swimmer in her youth and her passion for water activities continued throughout her short life. After her diagnosis of severe PAH, her life abruptly changed as she was placed on triple therapy, which consisted of an endothelin receptor antagonist (ERA), a phosphodiesterase-5 inhibitor (pde-5), and the IV epoprostenol. The patient experienced severe side effects that negatively impacted her ability to resume her activities of daily life and swimming. Although she remained hemodynamically stable on IV therapy, her poor quality of life and severe depression convinced her cardiologist that transitioning to an oral treprostinil would be the only option for her survival. At the time, there was a lack of clinical trials or guidelines to support the transition from IV to oral prostacyclins to follow, so an interdisciplinary team approach needed to be taken to ensure that the safety and efficacy of the transition would be maintained.https://scholarlycommons.baptisthealth.net/nhsrj/vol2/iss1/8/Pulmonary arterial hypertension (PAH)TransitionEpoprostenolTreprostinilQuality of life
collection DOAJ
language English
format Article
sources DOAJ
author Tina Hyman
Michael Salinero
Francisco Javier Jimenez-Carcamo
Margarita Pallares
Maribel Matos
spellingShingle Tina Hyman
Michael Salinero
Francisco Javier Jimenez-Carcamo
Margarita Pallares
Maribel Matos
Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study
Nursing & Health Sciences Research Journal
Pulmonary arterial hypertension (PAH)
Transition
Epoprostenol
Treprostinil
Quality of life
author_facet Tina Hyman
Michael Salinero
Francisco Javier Jimenez-Carcamo
Margarita Pallares
Maribel Matos
author_sort Tina Hyman
title Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study
title_short Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study
title_full Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study
title_fullStr Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study
title_full_unstemmed Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study
title_sort navigating a difficult transition in pulmonary arterial hypertension: a clinical case study
publisher Library & Knowledge Services and Nursing & Health Sciences Research Departments
series Nursing & Health Sciences Research Journal
issn 2578-3750
publishDate 2019-07-01
description Over the past 20 years, Pulmonary Arterial Hypertension (PAH) patients and providers have seen an increase in options to treat PAH. Currently, there are choices for the delivery of medications approved to treat patients with PAH where at one point the only option was intravenous (IV) therapy. This case study details the transition from IV Epoprostenol to oral Treprostinil for the treatment of a 53 year old female diagnosed with severe Pulmonary Arterial Hypertension whose quality of life became unbearable by the IV medication delivery route. This patient was a synchronized swimmer in her youth and her passion for water activities continued throughout her short life. After her diagnosis of severe PAH, her life abruptly changed as she was placed on triple therapy, which consisted of an endothelin receptor antagonist (ERA), a phosphodiesterase-5 inhibitor (pde-5), and the IV epoprostenol. The patient experienced severe side effects that negatively impacted her ability to resume her activities of daily life and swimming. Although she remained hemodynamically stable on IV therapy, her poor quality of life and severe depression convinced her cardiologist that transitioning to an oral treprostinil would be the only option for her survival. At the time, there was a lack of clinical trials or guidelines to support the transition from IV to oral prostacyclins to follow, so an interdisciplinary team approach needed to be taken to ensure that the safety and efficacy of the transition would be maintained.
topic Pulmonary arterial hypertension (PAH)
Transition
Epoprostenol
Treprostinil
Quality of life
url https://scholarlycommons.baptisthealth.net/nhsrj/vol2/iss1/8/
work_keys_str_mv AT tinahyman navigatingadifficulttransitioninpulmonaryarterialhypertensionaclinicalcasestudy
AT michaelsalinero navigatingadifficulttransitioninpulmonaryarterialhypertensionaclinicalcasestudy
AT franciscojavierjimenezcarcamo navigatingadifficulttransitioninpulmonaryarterialhypertensionaclinicalcasestudy
AT margaritapallares navigatingadifficulttransitioninpulmonaryarterialhypertensionaclinicalcasestudy
AT maribelmatos navigatingadifficulttransitioninpulmonaryarterialhypertensionaclinicalcasestudy
_version_ 1725909218517581824